Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 5, 2012, Pages 1138-1144

  Holler, Jes Gitz ^a   Christensen, S Brøgger ^a   Slotved, Hans Christian ^b   Rasmussen, Hasse B ^a   Gúzman, Alfonso ^a   Olsen, Carl Erik ^c   Petersen, Bent ^d   Mølgaard, Per ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d CARLSBERG LABORATORY   (Denmark)

Author keywords

Antibiotic resistance; Antibiotics; MRSA; Natural compounds

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN; CIPROFLOXACIN; ETHIDIUM BROMIDE; KAEMPFEROL 3 O ALPHA LEVO(2,4 BIS E PARA COUMAROYL)RHAMNOSIDE; KAEMPFEROL DERIVATIVE; NORA PROTEIN; PLANT EXTRACT; RESERPINE; UNCLASSIFIED DRUG; VERAPAMIL;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENTIATION; ESCHERICHIA COLI; GENE OVEREXPRESSION; IC 50; INTRACELLULAR TRANSPORT; MEDICINAL PLANT; MEMBRANE VESICLE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERSEA; PERSEA LINGUE; STAPHYLOCOCCUS AUREUS;

BACTERIAL PROTEINS; BIOLOGICAL ASSAY; CIPROFLOXACIN; DRUG SYNERGISM; ENZYME INHIBITORS; ESCHERICHIA COLI; ETHIDIUM; INHIBITORY CONCENTRATION 50; KAEMPFEROLS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PERSEA; PLANT EXTRACTS; STAPHYLOCOCCUS AUREUS;

EID: 84859561724     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks005     Document Type: Article

References (28)

1. Poole K. Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria. Antimicrob Agents Chemother 2000; 44: 2595-9.
2. Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem 2009; 78: 119-46.
3. DeMarco CE, Cushing LA, Frempong-Manso E et al. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51: 3235-9.
4. Tegos GP, Haynes M, Strouse JJ et al. Microbial efflux pump inhibition: tactics and strategies. Curr Pharm Des 2011; 17: 1291-302.
5. Smith EC, Kaatz GW, Seo SM et al. The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51: 4480-3.
6. Stavri M, Piddock LJ, Gibbons S. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 2007; 59: 1247-60.
7. Stermitz FR, Lorenz P, Tawara JN et al. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 2000; 97: 1433-7.
8. Holler JG, Sondergaard K, Slotved HC et al. Evaluation of the antibacterial activity of Chilean plants traditionally used for wound healing therapy against multidrug-resistant Staphylococcus aureus. Planta Med 2011; doi:10.1055/s-0031-1280316.
9. Bloor SJ. An antimicrobial kaempferol-diacyl-rhamnoside from Pentachondra pumila. Phytochemistry 1995; 38: 1033-5.
10. Fiorini C, David B, Fouraste I et al. Acylated kaempferol glycosides from Laurus nobilis leaves. Phytochemistry 1998; 47: 821-4.
11. Otsuka N, Liu MH, Shiota S et al. Anti-methicillin resistant Staphylococcus aureus (MRSA) compounds isolated from Laurus nobilis. Biol Pharm Bull 2008; 31: 1794-7.
12. Hossion AM, Otsuka N, Kandahary RK et al. Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents. Bioorg Med Chem Lett 2010; 20: 5349-52.
13. Ibrahim MA, Mansoor AA, Gross A et al. Methicillin-resistant Staphylococcus aureus (MRSA)-active metabolites from Platanus occidentalis (American sycamore). J Nat Prod 2009; 72: 2141-4.
14. Kaatz GW, Seo SM, Ruble CA. Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. J Infect Dis 1991; 163: 1080-6.
15. Yu JL, Grinius L, Hooper DC. NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes. J Bacteriol 2002; 184: 1370-7.
16. Sambrook J, Russell DW. Molecular Cloning-A Laboratory Manual (Third edn). Cold Spring Harbor: Cold Spring Harbour Laboratory Press, 2001.
17. Kaatz GW, Seo SM, O'Brien L et al. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrob Agents Chemother 2000; 44: 1404-6.
18. Lomovskaya O, Warren MS, Lee A et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105-16.
19. Kaatz GW, Moudgal VV, Seo SM et al. Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 719-26.
20. Stermitz FR, Scriven LN, Tegos G et al. Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus. Planta Med 2002; 68: 1140-1.
21. Morel C, Stermitz FR, Tegos G et al. Isoflavones as potentiators of antibacterial activity. J Agric Food Chem 2003; 51: 5677-9.
22. Markham PN, Westhaus E, Klyachko K et al. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43: 2404-8.
23. Palmgren MG. Acridine orange as a probe for measuring pH gradients across membranes: mechanism and limitations. Anal Biochem 1991; 192: 316-21.
24. Terland O, Gronberg M, Flatmark T. The effect of calcium channel blockers on the H(+)-ATPase and bioenergetics of catecholamine storage vesicles. Eur J Pharmacol 1991; 207: 37-41.
25. Thota N, Koul S, Reddy MV et al. Citral derived amides as potent bacterial NorA efflux pump inhibitors. Bioorg Med Chem 2008; 16: 6535-43.
26. Liu MH, Otsuka N, Noyori K et al. Synergistic effect of kaempferol glycosides purified from Laurus nobilis and fluoroquinolones on methicillinresistant Staphylococcus aureus. Biol Pharm Bull 2009; 32: 489-92.
27. Nemeth K, Plumb GW, Berrin JG et al. Deglycosylation by small intestinal epithelial cell β-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 2003; 42: 29-42.
28. Chambers HF, Deleo FR.Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7: 629-41.